Diabetes Leader USV slashes price of its popular Diabetes Medicine JALRA OD
Mumbai: With an aim to make its popular antidiabetic medicine more affordable and accessible to the Indian population, leading pharma company USV Ltd. has now reduced the price of its brand Jalra-OD. The once daily dosing tablet of JALRA OD which contains Vildagliptin 100mg SR will now be available at price of Rs 13.5 per tablet a sharp reduction from its earlier price of Rs 18...
Mumbai: With an aim to make its popular antidiabetic medicine more affordable and accessible to the Indian population, leading pharma company USV Ltd. has now reduced the price of its brand Jalra-OD.
The once daily dosing tablet of JALRA OD which contains Vildagliptin 100mg SR will now be available at price of Rs 13.5 per tablet a sharp reduction from its earlier price of Rs 18 per tablet.
Jalra-OD is the No.1 prescribed brand as per data from healthplix and is trusted by more than 50 thousand patients. Jalra-OD which contains Vildagliptin 100mg SR is a well studied molecule with 90% DPP4 inhibition while the DPP4 inhibition by Sita 100mg is 86.9%. Along with being efficacious Vildagliptin 100mg SR has proven its hepatic and cardiac safety.
Reference: Herman GA, et al. Clinical Pharmacology & Therapeutics. 2005; 78(6):675-88.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd